Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)-Reference-Cited by-同舟云学术

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)

Published:2017-04-26 Issue:10 Volume:31 Page:1686-1692
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Menter A.¹,Warren R.B.²,Langley R.G.³,Merola J.F.⁴,Kerr L.N.⁵,Dennehy E.B.⁵,Shrom D.⁵,Amato D.⁵,Okubo Y.⁶,Reich K.⁷

Affiliation:

1. Baylor University Medical Center; Dallas TX USA

2. Dermatology Centre; Salford Royal NHS Foundation Trust; Manchester Academic Health, Science Centre; University of Manchester; Manchester UK

3. Dalhousie University; Halifax NS Canada

4. Brigham and Women's Hospital; Harvard Medical School; Boston MA USA

5. Eli Lilly and Company; Indianapolis IN USA

6. Department of Dermatology; Tokyo Medical University; Tokyo Japan

7. Dermatologikum Hamburg and SCIderm GmbH; Hamburg Germany

Funder

AbbVie

Allergan

Amgen

Anacor

Boehringer Ingelheim

Celgene

Dermira

Janssen

Leo Pharma

Merck

Neothetics

Novartis

Pfizer

Regeneron Pharmaceuticals

Symbio/Maruho

Xenoport

Biogen Idec

Eli Lilly and Company

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14237/fullpdf

Reference23 articles.

1. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients;Adışen;J Eur Acad Dermatol Venereol,2009

2. Prevalence of psoriasis phenotypes among men and women in the USA;Merola;Clin Exp Dermatol,2016

3. Palmoplantar lesions in psoriasis: a study of 3065 patients;Kumar;Acta Derm Venereol,2002

4. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool;Farley;J Am Acad Dermatol,2009

5. Palmoplantar psoriasis and palmoplantar pustulosis: current treatment and future prospects;Raposo;Am J Clin Dermatol,2016

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region;Dermatology Practical & Conceptual;2024-07-31

2. Short‐term efficacy of tildrakizumab on difficult‐to‐treat areas: a real‐world experience;International Journal of Dermatology;2024-07-12

3. Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study;Dermatology and Therapy;2024-03-27

4. Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis;American Journal of Clinical Dermatology;2024-03-04

5. Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study;The Journal of Dermatology;2024-01-31